Research map: Clinical impact of salvage hepatectomy for local recurrence of hepatocellular carcinoma after radiofrequency ablation or selective transarterial chemoembolization

Back to the article

Papers in this map

  1. Sorafenib in Advanced Hepatocellular Carcinoma · Josep Maria Llovet · 2008 · 13127 citations · Cited by this paper
  2. Pretreatment serum vitamin D levels predict the therapeutic efficacy of atezolizumab plus bevacizumab therapy in advanced hepatocellular carcinoma: a multicenter analysis · 2026 · Related
  3. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma · Richard S. Finn · 2020 · 7562 citations · Cited by this paper
  4. Sex differences in the prognostic value of body mass index after curative nephrectomy for high-risk renal cell carcinoma: a multicenter cohort study · 2026 · Related
  5. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial · Ann‐Lii Cheng · 2008 · 5881 citations · Cited by this paper
  6. The role of surgical timing in survival of patients with spinal metastases · 2026 · Related
  7. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial · Masatoshi Kudo · 2018 · 5585 citations · Cited by this paper
  8. Racial disparities in time to treatment initiation and survival outcomes in patients with vulvar cancer: a national cancer database analysis · 2026 · Related
  9. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update · María Reig · 2021 · 4352 citations · Cited by this paper
  10. Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer · 2026 · Related
  11. Hepatocellular carcinoma · Alejandro Forner · 2012 · 4059 citations · Cited by this paper
  12. Clinical utility of comprehensive genomic profiling in thoracic malignancies beyond conventional gene testing · 2026 · Related
  13. Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma · Ann‐Lii Cheng · 2021 · 1752 citations · Cited by this paper
  14. Positive peritoneal cytology and recurrence patterns in endometrial cancer according to postoperative recurrence risk classification: a retrospective cohort study · 2026 · Related
  15. The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective · Alan Paul Venook · 2010 · 979 citations · Cited by this paper
  16. Efficacy of anti-GD2 antibody immunotherapy with filgrastim and teceleukin versus standard treatment with sargramostim, aldesleukin and isotretinoin in children with high-risk neuroblastoma · 2026 · Related
  17. Early-Stage Hepatocellular Carcinoma in Patients with Cirrhosis: Long-term Results of Percutaneous Image-guided Radiofrequency Ablation · Riccardo Antonio Lencioni · 2005 · 876 citations · Cited by this paper
  18. Prognostic significance of predicted skeletal muscle index after curative-intent resection for non-small cell lung cancer · 2026 · Related
  19. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update · Masatoshi Kudo · 2021 · 693 citations · Cited by this paper
  20. RNF125 mediates the anti-breast cancer activity of betulinic acid through ubiquitin-dependent degradation of MYH9 · 2026 · Related
  21. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update · Norihiro Kokudo · 2019 · 540 citations · Cited by this paper
  22. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma · Kelvin K. Ng · 2017 · 351 citations · Cited by this paper
  23. Comparison of long‐term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma · Yong Fang · 2013 · 233 citations · Cited by this paper
  24. REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset · Tatsuya Yamashita · 2019 · 233 citations · Cited by this paper
  25. Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trial) · Tadatoshi Takayama · 2021 · 209 citations · Cited by this paper
  26. Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor-1α and its significance · Seiichi Yasuda · 2003 · 145 citations · Cited by this paper
  27. Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation: Risk Factors and Clinical Significance · Tae Wook Kang · 2015 · 139 citations · Cited by this paper
  28. Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1α/VEGFA · Jian Kong · 2012 · 133 citations · Cited by this paper
  29. Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma · Yasutsugu Takada · 2003 · 87 citations · Cited by this paper
  30. Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization · Y‐B Kim · 2001 · 69 citations · Cited by this paper
  31. Co‐expression of Bcl‐2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization · Nao Kobayashi · 1999 · 68 citations · Cited by this paper
  32. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery · Mingsheng Huang · 2016 · 68 citations · Cited by this paper
  33. Expressions of Hypoxia-Inducible Factor-1 and Epithelial Cell Adhesion Molecule are Linked with Aggressive Local Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Therapy · Shinichiro Yamada · 2014 · 65 citations · Cited by this paper
  34. Epithelial–mesenchymal transition-related genes are linked to aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation · Shuichi Iwahashi · 2016 · 57 citations · Cited by this paper
  35. Percutaneous Radiofrequency Ablation and Transcatheter Arterial Chemoembolization for Hypervascular Hepatocellular Carcinoma: Rate and Risk Factors for Local Recurrence · Tomonori Murakami · 2007 · 55 citations · Cited by this paper
  36. Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation · Tetsuya Ikemoto · 2016 · 51 citations · Cited by this paper
  37. Ablation for Recurrent Hepatocellular Carcinoma: A Systematic Review of Clinical Efficacy and Prognostic Factors · Sarah C. Thomasset · 2015 · 40 citations · Cited by this paper
  38. Outcome of salvage hepatic resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy · Suguru Yamashita · 2014 · 36 citations · Cited by this paper
  39. Salvage Hepatectomy for Local Recurrent Hepatocellular Carcinoma After Ablation Therapy · Hiroyuki Sugo · 2012 · 29 citations · Cited by this paper

Source: OpenAlex (CC0)